Drug Shortage Report for CETROTIDE

Last updated on 2017-12-02 History
Report ID 25863
Drug Identification Number 02247766
Brand name CETROTIDE
Common or Proper name cetrorelix acetate
Company Name EMD SERONO, A DIVISION OF EMD INC., CANADA
Market Status MARKETED
Active Ingredient(s) CETRORELIX
Strength(s) 0.25MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 1 vial / flacon
ATC code H01CC
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-10-12
Estimated end date 2017-12-31
Actual end date 2017-12-01
Shortage status Resolved
Updated date 2017-12-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2695 NORTH SHERIDAN WAY, SUITE 200
MISSISSAUGA, ONTARIO
CANADA L5K 2N6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-10-13 English Compare
v2 2017-10-13 English Compare
v3 2017-10-13 English Compare
v4 2017-10-13 French Compare
v5 2017-10-13 English Compare
v6 2017-10-13 English Compare
v7 2017-10-13 French Compare
v8 2017-11-30 English Compare
v9 2017-11-30 French Compare
v10 2017-12-02 English Compare

Showing 1 to 10 of 10